Search for: "Foley & Lardner, LLP." Results 81 - 100 of 319
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 May 2023, 6:00 am by Jean O'Grady
”  LexisNexis is teaming up with leading Am Law 50 firms, such as Baker McKenzie, Reed Smith and Foley & Lardner, LLP, as part of its early Commercial Preview Program to tap into their expertise for advice and feedback. [read post]
3 Apr 2023, 10:00 pm by christina.reilly@829llc.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The post White House Report Identifies Precision Medicine for Future R & D Investment appeared first on Foley & Lardner LLP. [read post]
27 Mar 2023, 8:23 am by Daniel A. Kaplan
Should you have any questions on federal contractor compliance requirements, please reach out to your Foley & Lardner LLP contact who will be able to direct you to our attorneys who regularly counsel clients on these matters. [read post]
25 Mar 2023, 10:16 am by Rob Robinson
“Having the ability to customize queues, replace batch administration and templatize and transfer queues across workspaces has simplified the document review process immensely,” said Leslie Nash, Litigation Support Specialist at Foley & Lardner LLP. [read post]
13 Mar 2023, 10:00 pm by christina.reilly@829llc.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The post Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 appeared first on Foley & Lardner LLP. [read post]
9 Mar 2023, 7:18 am by Eric Blumrosen and Danielle E. Osburn
It is impossible to ignore the sector’s increase in participation in energy convergence efforts, and Foley & Lardner LLP has the broad range of legal expertise and experience needed to help facilitate your needs to further your energy convergence efforts, or assist you in entering this dynamic market for the first time. [read post]
2 Oct 2022, 10:00 pm by christina.reilly@829llc.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The post USPTO Extends Patents 4 Patients Program appeared first on Foley & Lardner LLP. [read post]
6 Sep 2022, 12:32 pm by Morgan McDonald
  Please reach out to your Foley & Lardner LLP Labor & Employment attorney for assistance with the Massachusetts law, or with paid family and medical leave requirements in any state where you have employees. [read post]
24 Aug 2022, 8:57 am by Rob Robinson
Paul, MN) Peter Vogel, Partner at Foley & Lardner (Dallas, TX) Ira Warshawsky (Ret.), Of Counsel at Meyer, Suozzi, English & Klein, PC (NY); New York Supreme Court Justice (1997-2011) Paul Weiner, Shareholder at Littler Mendelson (Philadelphia, PA) Jay Yelton, Of Counsel at Warner, Norcross + Judd (Michigan) The EDRM community is comprised of 33% corporations, 30% law firms and 23% software and service providers, 12% governments with the remaining 2% being a mix of… [read post]
16 Aug 2022, 5:58 am by Jean O'Grady
Sidley Austin; Pam Noyd, Information Resources Manager, Foley & Lardner LLP; Emily Rushing, Director Competitive Intelligence, Haynes & Boone LLP; Keli Whitnell, Senior Experience Database Mgr. [read post]
12 Aug 2022, 6:34 am by Dan Bressler
” “‘This is one of the first substantive pieces of guidance on Reg BI for the brokerage industry and the fiduciary standard for investment advisers’ under SEC Chairman Gary Gensler, Jim Lundy, a partner and member of the Securities Enforcement & Litigation Practice at Foley & Lardner LLP, said in an email. [read post]
5 Jul 2022, 10:00 pm by christina.reilly@829llc.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The post Impact of Current 101 Jurisprudence on Precision Medicine Innovation appeared first on Foley & Lardner LLP. [read post]
10 Mar 2022, 9:00 pm by christina.reilly@829llc.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The post Personalized Medicine: 2021 FDA Guideposts for Progress – Focus On Diagnostics appeared first on Foley & Lardner LLP. [read post]
2 Mar 2022, 9:00 pm by christina.reilly@829llc.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The post Personalized Medicine: 2021 FDA Guideposts for Progress – Focus on Therapeutics appeared first on Foley & Lardner LLP. [read post]
18 Feb 2022, 6:34 am by Andrew Lavoott Bluestone
Protostorm, Inc. v Foley & Lardner LLP, 2022 NY Slip Op 01107, Decided on February 17, 2022, Appellate Division, First Department is a short decision concerning a small act with big consequences. [read post]
8 Nov 2021, 6:33 am by Derek T. Muller
Firm D R D% Berger Montague $563,692 $0 100.0% Grant & Eisenhoffer $379,781 $0 100.0% Kaplan Fox $77,572 $0 100.0% Hagens Berman $71,775 $0 100.0% Hausfeld $35,142 $0 100.0% Berman Tabacco $21,182 $0 100.0% Joseph Saveri Law $6,284 $0 100.0% MoginRubin LLP $5,231 $0 100.0% Bernstein Liebhard $635 $0 100.0% Lief Cabraser $764,357 $30 100.0% Herman, Herman $284,946 $15 100.0% Bernstein Litowitz $205,015 … [read post]
8 Nov 2021, 6:33 am by Derek T. Muller
Firm D R D% Berger Montague $563,692 $0 100.0% Grant & Eisenhoffer $379,781 $0 100.0% Kaplan Fox $77,572 $0 100.0% Hagens Berman $71,775 $0 100.0% Hausfeld $35,142 $0 100.0% Berman Tabacco $21,182 $0 100.0% Joseph Saveri Law $6,284 $0 100.0% MoginRubin LLP $5,231 $0 100.0% Bernstein Liebhard $635 $0 100.0% Lief Cabraser $764,357 $30 100.0% Herman, Herman $284,946 $15 100.0% Bernstein Litowitz $205,015 … [read post]